Sonoma Pharmaceuticals Operating Income 2010-2024 | SNOA

Sonoma Pharmaceuticals operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Sonoma Pharmaceuticals Annual Operating Income
(Millions of US $)
2024 $-5
2023 $-5
2022 $-6
2021 $-3
2020 $-7
2019 $-11
2018 $-14
2017 $-13
2016 $-15
2015 $-7
2014 $-6
2013 $-3
2012 $-6
2011 $-8
2010 $-8
2009 $-17
Sonoma Pharmaceuticals Quarterly Operating Income
(Millions of US $)
2024-12-31 $-1
2024-09-30 $-1
2024-06-30 $-1
2024-03-31 $-1
2023-12-31 $-1
2023-09-30 $-1
2023-06-30 $-1
2023-03-31 $-1
2022-12-31 $-2
2022-09-30 $-1
2022-06-30 $-1
2022-03-31 $-3
2021-12-31 $-1
2021-09-30 $-1
2021-06-30 $-1
2021-03-31 $-3
2020-12-31 $0
2020-09-30 $0
2020-06-30 $-1
2020-03-31 $-3
2019-12-31 $-1
2019-09-30 $-1
2019-06-30 $-2
2019-03-31 $-3
2018-12-31 $-2
2018-09-30 $-3
2018-06-30 $-4
2018-03-31 $-5
2017-12-31 $-3
2017-09-30 $-3
2017-06-30 $-3
2017-03-31 $-3
2016-12-31 $-4
2016-09-30 $-3
2016-06-30 $-4
2016-03-31 $-6
2015-12-31 $-4
2015-09-30 $-2
2015-06-30 $-2
2015-03-31 $-2
2014-12-31 $-2
2014-09-30 $-2
2014-06-30 $-2
2014-03-31 $-2
2013-12-31 $-2
2013-09-30 $-1
2013-06-30 $-1
2013-03-31 $-1
2012-12-31 $-1
2012-09-30 $-1
2012-06-30 $0
2012-03-31 $-1
2011-12-31 $-2
2011-09-30 $-1
2011-06-30 $-2
2011-03-31 $-1
2010-12-31 $-2
2010-09-30 $-2
2010-06-30 $-2
2010-03-31 $-1
2009-12-31 $-2
2009-09-30 $-2
2009-06-30 $-2
2009-03-31 $-2
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.005B $0.013B
Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $82.901B 31.10
Zoetis (ZTS) United States $68.972B 25.73
Daiichi Sankyo, - (DSNKY) Japan $43.624B 22.19
Takeda Pharmaceutical (TAK) Japan $43.624B 8.68
Sandoz Group AG (SDZNY) Switzerland $19.765B 0.00
Merck (MKKGY) Germany $17.939B 14.85
Summit Therapeutics (SMMT) United States $16.896B 0.00
United Therapeutics (UTHR) United States $13.518B 11.96
Shionogi (SGIOY) Japan $12.590B 12.61
Neurocrine Biosciences (NBIX) United States $11.755B 40.26
IPSEN (IPSEY) France $9.548B 0.00
Orion OYJ (ORINY) Finland $8.544B 23.11
Corcept Therapeutics (CORT) United States $7.512B 61.07
Stevanato Group S.p.A (STVN) Italy $7.183B 43.93
Madrigal Pharmaceuticals (MDGL) United States $6.280B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.205B 0.00
Ionis Pharmaceuticals (IONS) United States $5.189B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 10.32
Soleno Therapeutics (SLNO) United States $3.702B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.930B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.854B 10.00
Hypermarcas (HYPMY) Brazil $2.687B 17.67
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.278B 12.46
BioCryst Pharmaceuticals (BCRX) United States $2.061B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.059B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.752B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.639B 0.00
Guardian Pharmacy Services (GRDN) United States $1.527B 0.00
Indivior (INDV) United States $1.521B 6.45
Evotec AG (EVO) Germany $1.449B 0.00
Dyne Therapeutics (DYN) United States $1.330B 0.00
ARS Pharmaceuticals (SPRY) United States $1.188B 0.00
Ocular Therapeutix (OCUL) United States $1.104B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.061B 21.22
Enliven Therapeutics (ELVN) United States $0.976B 0.00
Collegium Pharmaceutical (COLL) United States $0.934B 5.04
Harrow (HROW) United States $0.922B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.824B 0.00
Cronos Group (CRON) Canada $0.794B 0.00
Ardelyx (ARDX) United States $0.785B 0.00
Xeris Biopharma Holdings (XERS) United States $0.726B 0.00
AleAnna (ANNA) United States $0.706B 0.00
Akebia Therapeutics (AKBA) United States $0.643B 0.00
Xencor (XNCR) United States $0.579B 0.00
KalVista Pharmaceuticals (KALV) United States $0.564B 0.00
USANA Health Sciences (USNA) United States $0.544B 11.83
Regulus Therapeutics (RGLS) United States $0.543B 0.00
CytoDyn (CYDY) United States $0.532B 0.00
Bioventus (BVS) United States $0.523B 13.29
Savara (SVRA) United States $0.517B 0.00
Relay Therapeutics (RLAY) United States $0.475B 0.00
Elite Pharmaceuticals (ELTP) United States $0.471B 0.00
Altimmune (ALT) United States $0.462B 0.00
Zevra Therapeutics (ZVRA) United States $0.445B 0.00
Siga Technologies (SIGA) United States $0.424B 8.85
Theravance Biopharma (TBPH) Cayman Islands $0.421B 0.00
Tourmaline Bio (TRML) United States $0.398B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.388B 0.00
Verve Therapeutics (VERV) United States $0.384B 0.00
Organogenesis (ORGO) United States $0.382B 0.00
Oruka Therapeutics (ORKA) United States $0.364B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.327B 8.83
Nature's Sunshine Products (NATR) United States $0.263B 24.29
Heron Therapeutics (HRTX) United States $0.262B 0.00
ProKidney (PROK) United States $0.226B 0.00
Aquestive Therapeutics (AQST) United States $0.221B 0.00
MediWound (MDWD) Israel $0.210B 0.00
OmniAb (OABI) United States $0.186B 0.00
Nanobiotix S.A (NBTX) France $0.183B 0.00
Avita Medical (RCEL) United States $0.177B 0.00
Liminatus Pharma (LIMN) $0.169B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.162B 0.00
Inhibikase Therapeutics (IKT) United States $0.158B 0.00
4D Molecular Therapeutics (FDMT) United States $0.145B 0.00
Esperion Therapeutics (ESPR) United States $0.145B 0.00
Journey Medical (DERM) United States $0.138B 0.00
Nektar Therapeutics (NKTR) United States $0.133B 0.00
Korro Bio (KRRO) United States $0.133B 0.00
Aldeyra Therapeutics (ALDX) United States $0.130B 0.00
Wellgistics Health (WGRX) United States $0.129B 0.00
Aclaris Therapeutics (ACRS) United States $0.128B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Profound Medical (PROF) Canada $0.121B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Lyell Immunopharma (LYEL) United States $0.115B 0.00
Larimar Therapeutics (LRMR) United States $0.115B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.111B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.105B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.092B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Cassava Sciences (SAVA) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.089B 14.70
Lexeo Therapeutics (LXEO) United States $0.089B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.086B 0.00
Achieve Life Sciences (ACHV) Canada $0.086B 0.00
Dominari Holdings (DOMH) United States $0.085B 0.00
Galectin Therapeutics (GALT) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Telomir Pharmaceuticals (TELO) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Fractyl Health (GUTS) United States $0.075B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 55.11
Context Therapeutics (CNTX) United States $0.071B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Unicycive Therapeutics (UNCY) United States $0.067B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Vivani Medical (VANI) United States $0.060B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.050B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
PMV Pharmaceuticals (PMVP) United States $0.044B 0.00
Century Therapeutics (IPSC) United States $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.042B 0.00
Prelude Therapeutics (PRLD) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.039B 0.00
Avalo Therapeutics (AVTX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
FibroGen (FGEN) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Surrozen (SRZN) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.015B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.88
Talphera (TLPH) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Klotho Neurosciences (KLTO) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Incannex Healthcare (IXHL) Australia $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00